XML 19 R6.htm IDEA: XBRL DOCUMENT v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT) (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2023   39,973,202          
Beginning balance at Dec. 31, 2023 $ 635,854 $ 400 $ 1,400,479 $ 0 $ (555,895) $ (209,558) $ 428
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   423,805          
Issuance of restricted stock and other stock awards (2,774) $ 4 (2,778)        
Share-based compensation 3,058   3,058        
Other comprehensive income (loss) (14,045)         (14,045)  
Settlement of consideration (in shares)   86,368          
Settlement of consideration (124) $ 1 (125)        
Other 1,750   1,750        
Net income (loss) (173,914)       (173,914)    
Ending balance (in shares) at Mar. 31, 2024   40,483,375          
Ending balance at Mar. 31, 2024 449,805 $ 405 1,402,384 0 (729,809) (223,603) 428
Beginning balance (in shares) at Dec. 31, 2023   39,973,202          
Beginning balance at Dec. 31, 2023 635,854 $ 400 1,400,479 0 (555,895) (209,558) 428
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) 69,313            
Net income (loss) (481,965)            
Ending balance (in shares) at Sep. 30, 2024   40,653,346          
Ending balance at Sep. 30, 2024 233,843 $ 406 1,411,114 0 (1,037,860) (140,245) 428
Beginning balance (in shares) at Mar. 31, 2024   40,483,375          
Beginning balance at Mar. 31, 2024 449,805 $ 405 1,402,384 0 (729,809) (223,603) 428
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   135,981          
Issuance of restricted stock and other stock awards 263 $ 1 262 0      
Share-based compensation 4,472   4,472        
Other comprehensive income (loss) (793)         (793)  
Net income (loss) (60,196)       (60,196)    
Ending balance (in shares) at Jun. 30, 2024   40,619,356          
Ending balance at Jun. 30, 2024 393,551 $ 406 1,407,118 0 (790,005) (224,396) 428
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   33,990          
Issuance of restricted stock and other stock awards (103)   (103) 0      
Share-based compensation 4,099   4,099        
Other comprehensive income (loss) 84,151         84,151  
Net income (loss) (247,855)       (247,855)    
Ending balance (in shares) at Sep. 30, 2024   40,653,346          
Ending balance at Sep. 30, 2024 $ 233,843 $ 406 1,411,114 0 (1,037,860) (140,245) 428
Beginning balance (in shares) at Dec. 31, 2024 40,787,007 40,787,007          
Beginning balance at Dec. 31, 2024 $ 30,902 $ 408 1,414,410 0 (1,123,649) (260,267) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   19,660          
Issuance of restricted stock and other stock awards (76)   (76)        
Share-based compensation 1,954   1,954        
Other comprehensive income (loss) (9,443)         (9,443)  
Net income (loss) (51,024)       (51,024)    
Ending balance (in shares) at Feb. 07, 2025   40,806,667          
Ending balance at Feb. 07, 2025 (27,687) $ 408 1,416,288 0 (1,174,673) (269,710) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Other comprehensive income (loss) 66,085            
Net income (loss) $ (300,119)            
Ending balance (in shares) at Sep. 30, 2025 49,131,302 49,131,302          
Ending balance at Sep. 30, 2025 $ 521,899 $ 490 751,804 0 (296,832) 66,085 352
Beginning balance (in shares) at Feb. 08, 2025   71,258,763          
Beginning balance at Feb. 08, 2025 1,172,536 $ 712 1,171,824 0 0 0 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share repurchases (in shares)   (22,804,384)          
Share repurchases (420,342) $ (228) (420,114)        
Issuance of restricted stock and other stock awards (in shares)   557,417          
Issuance of restricted stock and other stock awards (5,127) $ 5 (5,132)        
Bally’s Chicago Inc. Issuance 12,361           12,361
Share-based compensation 2,740   2,740        
Other comprehensive income (loss) 12,163         12,163  
Net income (loss) 34,516       34,516    
Ending balance (in shares) at Mar. 31, 2025   49,011,796          
Ending balance at Mar. 31, 2025 808,847 $ 489 749,318 0 34,516 12,163 12,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   108,301          
Issuance of restricted stock and other stock awards (224) $ 1 (225)        
Share-based compensation 2,350   2,350        
Other comprehensive income (loss) 61,216         61,216  
Other (1,314)   (1,314)        
Net income (loss) (228,436)       (228,436)    
Ending balance (in shares) at Jun. 30, 2025   49,120,097          
Ending balance at Jun. 30, 2025 642,439 $ 490 750,129 0 (193,920) 73,379 12,361
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of restricted stock and other stock awards (in shares)   11,205          
Issuance of restricted stock and other stock awards (263)   (263)        
Share-based compensation 1,938   1,938        
Bally’s Chicago Inc. Issuance (8,722)           (8,722)
Other comprehensive income (loss) (7,294)         (7,294)  
Net income (loss) $ (106,199)       (102,912)   (3,287)
Ending balance (in shares) at Sep. 30, 2025 49,131,302 49,131,302          
Ending balance at Sep. 30, 2025 $ 521,899 $ 490 $ 751,804 $ 0 $ (296,832) $ 66,085 $ 352